Drug Discovery Today

JANUARY 13, 2020

The participants of the EIT Health Headstart Programme will receive strong regional support and integration into the ecosystem, as well as funding to bring their innovations to the market. Headstart start-ups address disease areas and challenges from Parkinson’s to obesity, with the innovations spanning the categories of medtech, digital health and biotech.

Marketing 40

Marketing 40

Drug Discovery Today

JANUARY 13, 2020

CAMBRIDGE, UK, and LEUVEN, Belgium, 13 January 2020 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has partnered with imec, a world-leading research and innovation hub active in the fields of nanoelectronics and digital technologies, to increase production of Evonetix’s proprietary microelectromechanical systems (MEMS)-based silicon chips, enabling the platform to be manufactured at

DNA 40

DNA Production Gene Manufacturing 40

Drug Discovery Today

JANUARY 13, 2020

Joint Venture to develop next generation cell and gene therapies incorporating Affimer proteins

Gene Therapy 40

Gene Therapy Protein Gene Development 40

Drug Discovery Today

JANUARY 13, 2020

Researchers at the University of Dundee are aiming to make a breakthrough against tuberculosis.

Research 40

Research 40

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research